Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

17

Sep 2019

Hansoh Pharma and Atomwise start strategic collaboration on AI drug discovery for multiple therapeutic areas

Major Chinese biopharmaceutical company Hansoh Pharmaceutical Group Company Limited Hanmori Pharmaceutical Group Co Ltd Hanso Pharmaceutical and AI Atomwise Inc a leader in the field announced the collaboration The purpose of the collaboration is to design and discover potential drug candidates for...

17

Sep 2019

AlivaMab Discovery Services Announces Multi-Target Agreement with Janssen

AlivaMab Discovery Services LLC a company providing custom human therapeutic antibody drug discovery services using the AlivaMab Mouse a bestinclass antibody discovery platform today announced a multitarget discovery agreement with Janssen Research Development LLC Janssen Under the agreement ADS wi...

16

Sep 2019

Akari Therapeutics Nomacopan Granted U.S. Orphan Drug Designation for Bullous Pemphigoid

Akari Therapeutics Plc a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where the complement C andor leukotriene LTB systems are implicated today announced that the US Food and Drug Administration FDA has granted orphan drug designat...

13

Sep 2019

Hansen Pharmaceuticals and Atomwise Launch Strategic Collaboration on Artificial Intelligence Drug Discovery in Multiple Therapeutic Areas

Chinas leading biopharmaceutical company Hansoh Pharmaceutical Group Company Limited Hansen Pharmaceutical and drug discovery artificial intelligence AI Atomwise Inc Atomwise a leader in the field announced a collaborative design and discovery of potential drug candidates for up to unexposed t...

press releasesRead more...

17

Sep 2019

Helsinn and Mundipharma China Pharmaceutical jointly announce approval of the oral formulation of Akynzeo® in China

Helsinn a Swiss pharmaceutical group focused on building quality cancer care products and Mundipharma China Pharmaceutical the market leader in pain management today jointly announce that the National Medical Products Administration NMPA has approved the oral formulation of Akynzeo for the treatment...

17

Sep 2019

Glenmark Receives Orphan Drug Designation for GBR 1342, a Bispecific Antibody Candidate Under Evaluation for the Treatment of Multiple Myeloma

Glenmark Pharmaceuticals a researchled integrated global pharmaceutical company today announced that the US Food and Drug Administration FDA has granted Orphan Drug Designation to its bispecific antibody candidate GBR for the treatment of patients with multiple myeloma who have received prior thera...

16

Sep 2019

Eisai and Biogen to Discontinue Phase III Clinical Studies of Bace Inhibitor Elenbecestat in Early Alzheimer's Disease

Eisai Co Ltd and Biogen Inc today announced the decision to discontinue the Phase III clinical studies MISSION AD AD on the investigational oral BACE beta amyloid cleaving enzyme inhibitor elenbecestat development code E in patients with early Alzheimers disease AD

13

Sep 2019

Phillips-Medisize Enters Agreement with Global Pharmaceutical Company to Acquire Exclusive Ownership of Patents for an Innovative Mini-tablet Dispenser

PhillipsMedisize a Molex company announced today an agreement with a Global Pharmaceutical Company where PhillipsMedisize acquired exclusive ownership of patents supporting an innovative minitablet dispenser to accommodate the varied and customized oral dispensing needs of patients

EventsRead more...

18 - 20

Sep 2019

Nutraceutical and Functional Food Summit

Crowne Plaza Beijing Chaoyang U-Town

18 - 19

Sep 2019

Pharma CI USA Conference & Exhibition

Pharma CI Conference
Newark Liberty International Airport Marriot

19 - 21

Sep 2019

International Gynecologic Cancer Society

Kenes Group
Windsor Convention & Expo Center

19 - 21

Sep 2019

International Gynecologic Cancer Society

Windsor Convention Expo Center

19 - 19

Sep 2019

20 - 21

Sep 2019

Asthma, Allergy & COPD Forum

Maarefah Management
Conrad Hotel

Advertisements

TOP ARTICLES

KNOWLEDGE BANK

  • Interviews

    Merck

    Staff Engineer, Manufacturing Science and Technology, South East Asia

    Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot...

EDITORIAL SECTION

  • STRATEGY

    REDUCTION OF HEALTH COSTS

    Since autumn the first package of costcutting measures in Switzerlands healthcare system is being reviewed One of the measures is the socalled refere...